Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis

Background Liver fibrosis is often a consequence of chronic liver injury, and has the potential to progress to cirrhosis and liver cancer. Despite being an important human disease, there are currently no approved anti-fibrotic drugs. In this study, we aim to identify the key genes and pathways gover...

Full description

Bibliographic Details
Main Authors: Zhu Zhan, Yuhe Chen, Yuanqin Duan, Lin Li, Kenley Mew, Peng Hu, Hong Ren, Mingli Peng
Format: Article
Language:English
Published: PeerJ Inc. 2019-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/6645.pdf